Prognostic impact and clinicopathological correlations of the cribriform pattern in pulmonary adenocarcinoma

Journal of Thoracic Oncology

Volumn 10, Issue 4, 2015, Pages 638-644

  Warth, Arne ^a,b   Muley, Thomas ^b,c   Kossakowski, Claudia ^a   Stenzinger, Albrecht ^a   Schirmacher, Peter ^a   Dienemann, Hendrik ^b,c   Weichert, Wilko ^a,d  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b German Center for Lung Research (DZL)   (Germany)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Adenocarcinoma; Classification; Pattern; Prognosis

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; K RAS PROTEIN;

ACINAR CELL CARCINOMA; ADULT; ARTICLE; BILOBECTOMY; CANCER GROWTH; CANCER PROGNOSIS; CANCER SURVIVAL; CRIBRIFORM PATTERN; DISEASE FREE SURVIVAL; FEMALE; GENE MUTATION; HISTOLOGY; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; LUNG ADENOCARCINOMA; LUNG LOBECTOMY; LUNG RESECTION; LYMPH NODE DISSECTION; MAJOR CLINICAL STUDY; MALE; MICROPAPILLARY CARCINOMA; MUTATIONAL ANALYSIS; OVERALL SURVIVAL; PAPILLARY CARCINOMA; PRIORITY JOURNAL; SEGMENTECTOMY; SOLID TUMOR; WEDGE RESECTION; ADENOCARCINOMA; AGED; EPIDEMIOLOGY; GERMANY; KAPLAN MEIER METHOD; LUNG NEOPLASMS; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SURVIVAL RATE; TRENDS; TUMOR INVASION; TUMOR RECURRENCE; VERY ELDERLY;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; DISEASE-FREE SURVIVAL; FEMALE; GERMANY; HUMANS; KAPLAN-MEIER ESTIMATE; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PNEUMONECTOMY; PROGNOSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84938287250     PISSN: 15560864     EISSN: 15561380     Source Type: Journal    
DOI: 10.1097/JTO.0000000000000490     Document Type: Article

References (23)

1. Travis WD, Brambilla E, Noguchi M, International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol 2011 6 244 285
2. Russell PA, Wainer Z, Wright GM, Daniels M, Conron M, Williams RA, Does lung adenocarcinoma subtype predict patient survival? A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma classification. J Thorac Oncol 2011 6 1496 1504
3. Thunnissen E, Beasley MB, Borczuk AC, Reproducibility of histopathological subtypes and invasion in pulmonary adenocarcinoma An international interobserver study. Mod Pathol 2012 25 1574 1583
4. Tsuta K, Kawago M, Inoue E, The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer 2013 81 371 376
5. Warth A, Cortis J, Fink L, Pulmonary Pathology Working Group of the German Society of Pathology Training increases concordance in classifying pulmonary adenocarcinomas according to the novel IASLC/ATS/ERS classification. Virchows Arch 2012 461 185 193
6. Warth A, Muley T, Meister M, The novel histologic International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society classification system of lung adenocarcinoma is a stage-independent predictor of survival. J Clin Oncol 2012 30 1438 1446
7. Warth A, Stenzinger A, von Brünneck AC, Interobserver variability in the application of the novel IASLC/ATS/ERS classification for pulmonary adenocarcinomas. Eur Respir J 2012 40 1221 1227
8. Xu L, Tavora F, Battafarano R, Burke A, Adenocarcinomas with prominent lepidic spread: retrospective review applying new classification of the American Thoracic Society. Am J Surg Pathol 2012 36 273 282
9. Yoshizawa A, Motoi N, Riely GJ, Impact of proposed IASLC/ATS/ERS classification of lung adenocarcinoma: prognostic subgroups and implications for further revision of staging based on analysis of 514 stage I cases. Mod Pathol 2011 24 653 664
10. Xu L, Tavora F, Burke A, Histologic features associated with metastatic potential in invasive adenocarcinomas of the lung. Am J Surg Pathol 2013 37 1100 1108
11. Kadota K, Yeh YC, Sima CS, The cribriform pattern identifies a subset of acinar predominant tumors with poor prognosis in patients with stage I lung adenocarcinoma: a conceptual proposal to classify cribriform predominant tumors as a distinct histologic subtype. Mod Pathol 2014 27 690 700
12. Pathology and Genetics. Tumours of the Lung, Pleura, Thymus and Heart 2004 Geneva WHO Press
13. TNM Classification of Malignant Tumours 2009 John Wiley and Sons, Ltd
14. Warth A, Muley T, Herpel E, Large-scale comparative analyses of immunomarkers for diagnostic subtyping of non-small-cell lung cancer biopsies. Histopathology 2012 61 1017 1025
15. Warth A, Cortis J, Soltermann A, Tumour cell proliferation (Ki-67) in non-small cell lung cancer: a critical reappraisal of its prognostic role. Br J Cancer 2014 111 1222 1229
16. Warth A, Penzel R, Lindenmaier H, EGFR, KRAS, BRAF and ALK gene alterations in lung adenocarcinomas: patient outcome, interplay with morphology and immunophenotype. Eur Respir J 2014 43 872 883
17. Warth A, Muley T, Dienemann H, ROS1 expression and translocations in non-small-cell lung cancer: clinicopathological analysis of 1478 cases. Histopathology 2014 65 187 194
18. Petersen I, Warth A, [Lung cancer. Developments, concepts and preview of the new WHO classification]. Pathologe 2014 35 547 556
19. Travis WD, The 2015 WHO classification of lung tumors. Pathologe 2014 35 Suppl 2 188
20. Moreira AL, Joubert P, Downey RJ, Rekhtman N, Cribriform and fused glands are patterns of high-grade pulmonary adenocarcinoma. Hum Pathol 2014 45 213 220
21. Wang C, Durra HY, Huang Y, Manucha V, Interobserver reproducibility study of the histological patterns of primary lung adenocarcinoma with emphasis on a more complex glandular pattern distinct from the typical acinar pattern. Int J Surg Pathol 2014 22 149 155
22. Mackinnon AC Jr, Luevano A, de Araujo LC, Rao N, Le M, Suster S, Cribriform adenocarcinoma of the lung: clinicopathologic, immunohistochemical, and molecular analysis of 15 cases of a distinctive morphologic subtype of lung adenocarcinoma. Mod Pathol 2014 27 1063 1072
23. Maeshima AM, Tochigi N, Yoshida A, Asamura H, Tsuta K, Tsuda H, Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator. J Thorac Oncol 2010 5 333 339